| Literature DB >> 36212443 |
An-Qi Zhang1, Hui-Ping Zhao2, Fei Li3, Pan Liang1,4, Jian-Bo Gao1,4, Ming Cheng4,5.
Abstract
Purpose: Preoperative evaluation of lymph node metastasis (LNM) is the basis of personalized treatment of locally advanced gastric cancer (LAGC). We aim to develop and evaluate CT-based model using deep learning features to preoperatively predict LNM in LAGC.Entities:
Keywords: computed tomography; deep learning; locally advanced gastric cancer; lymph node metastasis; radiomics
Year: 2022 PMID: 36212443 PMCID: PMC9537615 DOI: 10.3389/fonc.2022.969707
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Flow chart of patient selection.
Figure 2Analysis flowchart. (A, B) Features extraction from the deep learning method and handcrafted radiomics method. (C) Machine learning methods were employed in model construction. (D) Model evaluation. CNN, convolutional neural network; LASSO, the least absolute shrinkage and selection operator; SVM, support vector machine; AUC, area under the receiver operating characteristic curve; DCA, decision curve analysis.
The clinical characteristics of patients in the training and testing cohorts.
| Characteristics | Training cohort (120: 247) | Testing cohort (47: 109) | ||||
|---|---|---|---|---|---|---|
| LNM (-) | LNM (+) | P value | LNM (-) | LNM (+) | P value | |
| Age (mean ± SD, years) | 59.98 ± 10.53 | 59.83 ± 10.40 | 0.834 | 60.98 ± 10.91 | 58.66 ± 9.46 | 0.182 |
| Sex | ||||||
| Female | 28 (23.3) | 66 (26.7) | 0.569 | 16 (13.04) | 24 (22.0) | 0.168 |
| Male | 92 (76.7) | 181 (73.3) | 31 (86.96) | 85 (78.0) | ||
| Location | ||||||
| Cardia/fundus | 67 | 130 | 0.453 | 26 | 52 | 0.655 |
| Body | 23 | 51 | 11 | 26 | ||
| Antrum | 29 | 57 | 10 | 29 | ||
| More than two-thirds of stomach | 1 | 9 | 0 | 2 | ||
| Tumor thickness ± SD (mm) | 22.65 ± 8.58 | 23.43 ± 7.70 | 0.383 | 21.71 ± 7.67 | 21.93 ± 7.46 | 0.865 |
| Tumor diameter ± SD (mm) | 82.60 ± 41.59 | 94.22 ± 51.70 | 0.032* | 70.29 ± 30.46 | 90.36 ± 51.69 | 0.014* |
| Clinical T stage | ||||||
| T2 | 13 | 21 | 0.005* | 9 | 13 | 0.006* |
| T3 | 81 | 130 | 33 | 57 | ||
| T4a | 26 | 96 | 5 | 39 | ||
| CT-reported LN | ||||||
| Negative | 90 | 76 | <0.001* | 39 | 37 | <0.001* |
| Positive | 30 | 181 | 8 | 72 | ||
LNM, lymph node metastasis; (-), negative; (+), positive; *p < 0.05.
Predictive performance of radiological or clinical models in the testing cohort.
| AUC | Accuracy | Sensitivity | Specificity | PPV | NPV | |
|---|---|---|---|---|---|---|
| InceptionResNetV2 | 0. 707 | 65.6 | 67.9 | 60.8 | 78.3 | 47.7 |
| (0.653, 0.771) | (60.1, 72.7) | (55.9, 72.2) | (56.2, 73.3) | (73.0, 85.3) | (31.7, 53.8) | |
| VGG16 | 0.661 | 61.8 | 65.2 | 58.0 | 63.2 | 60.0 |
| (0.540, 0.745) | (55.7, 70.6) | (60.6, 69.9) | (51.8, 65.8) | (55.5, 70.0) | (53.7, 69.4) | |
| VGG19 | 0.578 | 49.6 | 40.6 | 68.6 | 72.9 | 35.7 |
| (0.507, 0.661) | (41.7, 55.1) | (40.6, 51.9) | (63.0, 75.6) | (66.0, 80.6) | (30.6, 47.9) | |
| ResNet50 | 0.796 | 75.2 | 80.2 | 64.7 | 82.5 | 61.1 |
| (0.715-0.865) | (67.2, 81.5) | (75.4, 84.2) | (58.2, 71.6) | (74.9, 87.3) | (55.5, 69.3) | |
| Xception | 0.660 | 62.4 | 65.1 | 56.9 | 75.8 | 43.9 |
| (0.607, 0.759) | (56.2, 71.6) | (52.2, 69.0) | (49.8, 68.7) | (70.9, 81.1) | (40.9, 51.6) | |
| Radiomics | 0.704 | 61.8 | 56.5 | 73.5 | 82.4 | 43.4 |
| (0.625, 0.783) | (54.5, 69.9) | (50.8,62.3) | (68.8, 79.8) | (75.8,87.3) | (40.8, 52.1) | |
| Clinical signature | 0.683 | 68.2 | 67.6 | 67.7 | 70.7 | 53.6 |
| (0.632, 0.721) | (65.3, 72.1) | (63.5,70.1) | (63.1, 71.6) | (67.5, 75.2) | (50.7, 61.9) |
Figure 3Evaluation of predictive performances for ResNet-SVM model and radiomics model. (A) The ROC curves showing the predictive performances of the ResNet and the radiomics model in testing cohorts. (B) The ROC curves showing the predictive performances of the ResNet and the radiomics model in training cohorts. (C, D) Curves of calibration analysis and the decision curve analysis for the ResNet and radiomics model. AUC, area under the receiver operating characteristic curve; LNM, lymph node metastasis.
Figure 4Grad-CAM visualizations for the feature heatmaps of representative patients generated from the ResNet. The right color bar indicates the scaled weights of deep features.